EXPLORING THE THERAPEUTIC POTENTIAL OF SGLT2 INHIBITORS: MARKET INSIGHTS

The SGLT2 inhibitors market is expanding rapidly due to the increasing prevalence of type 2 diabetes and rising demand for advanced treatments addressing cardiovascular and renal complications. Sodium-glucose co-transporter-2 (SGLT2) inhibitors are an essential class of drugs known for reducing blood glucose levels by encouraging glucose excretion